Saint Petersburg, Russia
BIOCAD is Russia's leading innovative biotechnology company with a focus on Biotechnology, Health Care, and Manufacturing. Since its establishment in 2001, the company has positioned itself as a global player with the slogan "Science for life!" BIOCAD stands out as one of the world's few full-cycle drug development and manufacturing companies, covering everything from new molecule discovery and genetic engineering to large-scale commercial production and marketing support.
The company boasts a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure that complies with international standards. BIOCAD's medicines are dedicated to treating complex health conditions such as cancer, HIV and Hepatitis C infections, and multiple sclerosis, among others.
Despite the lack of specific details on its last investment, BIOCAD's unique position in the biotechnology and pharmaceutical space, along with its impressive track record, make it an intriguing prospect for potential venture capital investments. With its headquarters in Russia, the company is well-positioned to expand its global reach and continue making significant contributions to the field of biotechnology.
